1.
Post-transplant Diabetes Mellitus in HBV Related Recipients
乙肝相关性终末期肝病肝移植术后糖尿病分析
2.
Association of the clinical features with pathology at end-stage liver disease
终末期肝病患者临床特点与病理联系
3.
Perioperative protection of organs during liver transplantation in patients with advanced liver disease
终末期肝病肝移植治疗围术期器官保护
4.
Evaluation Studies of MELD to Asses the Prognosis of Patients with Severe Hepatitis;
终末期肝病模型（MELD）对重型肝炎预后评价研究
5.
Clinical features and outcome of pediatric liver transplantation
小儿终末期肝病肝移植术式选择(附15例报告)
6.
Consummating of the model for end stage liver disease and its prognostic value in liver transplantation
终末期肝病模型评分的完善与肝移植预后
7.
Contrastive Study on Hepatitis B Virus Transcript of Liver Tissue and Serum in Patients with End-stage Liver Disease;
终末期肝病患者肝组织和血清中乙型肝炎病毒转录体的对照研究
8.
Studies on the Therapy of End-stage Liver Disease by Bone Marrow Stem Cells Transplantation;
骨髓干细胞移植治疗终末期肝病的研究
9.
A Clinical Study on Hepatitis B Related End-stage Liver Disease with Active Cytomegalovirus Infection in Patients
乙肝相关性终末期肝病患者活动性巨细胞病毒感染的临床研究
10.
Analysis of Prognosis in Patients with Decompensated Cirrhosis by the Model for End-stage Liver Disease and Its Longitudinal Modifications;
终末期肝病模型及其变化对失代偿期肝硬化患者的预后分析
11.
Pretransplantation MELD Score Predicts Short-term Survival of Patients with Benign End-stage Liver Disease Past-Liver Transplantation;
MELD评分预测良性终末期肝病肝移植术后短期生存率的初步研究
12.
The delta value of model of end stage liver disease in predicting the prognosis of patients with decompensated cirrhosis
终末期肝病模型评分差值对失代偿期肝硬化患者预后评估的价值
13.
Values of end-stage liver disease model in assessment of prognosis in patients with decompensated liver cirrhosis
终末期肝病模型评估失代偿期肝硬化患者预后的价值
14.
MELD scores and prognosis of patients with decompensated liver cirrhosis treated by traditional Chinese medicine
终末期肝病模型在中医药治疗失代偿期肝硬化患者时的应用价值
15.
The analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the model for end-stage liver disease and Child-Pugh grading
终末期肝病模型及Child-Pugh分级对失代偿期肝硬化患者的预后分析
16.
The clinical significance of serum VEGF and MELD in patients with liver cirrhosis
肝硬化患者VEGF水平和终末期肝病模型评分的临床意义
17.
Risk factor analysis of liver transplantation in the treatment of end-stage liver disease with portal hypertension
肝移植治疗终末期肝病合并门静脉高压症预后影响因素分析
18.
Clinical value of MELD in emergency preoperation of spontaneous rupture of primary hepatocellular carcinoma
终末期肝病模型在肝癌破裂出血急诊术前评估中的应用